<DOC>
	<DOC>NCT02192320</DOC>
	<brief_summary>To evaluate Efficacy and Safety of oral Atorvastatin and Dexamethasone on conservative treatment for Chronic Subdural Hematoma (CSDH) patients with Coagulation Disorders</brief_summary>
	<brief_title>The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders</brief_title>
	<detailed_description>Study design: Two-arm,Evaluator-blinded study Subjects: CSDH patients with Coagulation Disorders（Conservative treatment is adopted） Sample size: 60 cases, 30 in Atorvastatin and Dexamethasone-treated group, 30 in Atorvastatin-treated group.</detailed_description>
	<mesh_term>Hematoma</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Hematoma, Subdural</mesh_term>
	<mesh_term>Hematoma, Subdural, Chronic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1. Age ≥18 and＜90years old, both gender; 2. Longterm antiplatelet and anticoagulant drugs cause Coagulation Disorders; 3. CT scan reveals supratentorial, unilateral or bilateral chronic subdural hematoma (MRI scan is warranted if diagnosis is difficult); 4. The midline shift to less than 1 cm; 5. Attending physician makes a judgment that cerebral hernia would not occur and surgical operation might not be performed in a short time. Conservative treatment is adopted; 6. Patients have never undergo surgery on the hematoma; 7. Patient fully understood the nature of the study, and voluntarily participates and signs informed consent. 1. Allergic to the statin and dexamethasone or its ingredients; 2. Hematoma caused by tumors, blood and other known comorbidities; 3. Abnormal liver function; 4. Uncontrolled hepatitis and other liver diseases, as well as suffering from other disease may interfere the study; 5. Patients have been on oral Statin treatment in the past four weeks; 6. Patients have been on oral Steroids treatment for a long time; 7. Diagnosed Diabetes patients with poorly controlled blood glucose 8. Participate in clinical trials in the past four weeks; 9. Pregnant or breastfeeding; 10. Failure of completing the trial by poor compliance; 11. For any reason, the researchers believe that the case is not suitable for inclusion.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Atorvastatin</keyword>
	<keyword>Atorvastatin and Dexamethasone</keyword>
	<keyword>Chronic Subdural Hematoma</keyword>
	<keyword>conservative treatment</keyword>
</DOC>